Famotidine |
|
| Description | Famotidine (INN) is a histamine H2-receptor antagonist that inhibits stomach acid production, and it is commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD). It is commonly marketed by Johnson & Johnson/Merck under the trade names Pepcidine and Pepcid. Unlike cimetidine, the first H2 antagonist, |
| Therapeutic Low | 0.0200 |
| Therapeutic High | 0.1500 |
| Units | ug/mL |
| Specimen | P |
| Half Life Low | 2.00 |
| Half Life High | 5.00 |
| VOD Low | 1.00 |
| VOD High | 1.30 |
| Toxic Level | 0.000 |
| Lethal Level | 0.000 |
| Plasma to Whole Blood ratio | 0.00 |
| Warnings | |